Experimental Drug Could Help People With Asthma Copd Cystic Fibrosis And Cancer Related Lung Disease
Experimental drug reduces airway mucus that exacerbates common lung diseases. A multicenter research team co-led by The University of Texas MD Anderson Cancer Center developed the first drug to treat the uncontrolled secretion of mucins in the airways, which causes potentially life-threatening symptoms in millions of Americans with asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis (CF), as well as lung disease resulting from cancer and cancer treatment. The study was published today (March 23, 2022) in Nature....